* LIVE VIRTUAL COURSE VIA 2-WAY VIDEO CONFERENCE *
May 13, 2021, 6:00-7:30pm Pacific Time
Note: this lecture will only be available to registrants as a live webcast. Live attendance is expected and a recording of this program will not be made publicly available.
COVID-19 and Occupational Medicine: Vaccines, Variants, and Returning to Campus and the Workplace
Geoffrey Gottlieb, MD, PhD -- Chair of the UW Advisory Committee on Communicable Diseases, Medical Director of UW EH&S, Professor of Medicine & Global Health and an infectious diseases specialist at UW Medicine
David N. Weissman, MD -- Director of the Respiratory Health Division for NIOSH (the National Institute of Occupational Safety & Health), liaison to the Essential Workers team that is part of the CDC COVID-19 Vaccine Task Force, Adjunct Professor, Department of Medicine – Pulmonary and Critical Care Medicine, University of West Virginia
To continue our UW Occupational Medicine Grand Rounds series on COVID-19 and the practice of occupational medicine:
Dr. Geoffrey Gottlieb--Chair of the UW Advisory Committee on Communicable Diseases, Medical Director of UW EH&S, Professor of Medicine & Global Health and an infectious diseases specialist at UW Medicine--will discuss the latest information on COVID-19 on campuses and other workplaces, and on COVID-19 vaccines: approvals, rollouts, and updates on efficacy of the vaccines against the variants of concern. Discussion will include: future boosters, progress towards “herd immunity”, and the challenges of vaccination rollout and vaccine requirement policies, especially on university campuses and workplaces.
Dr. David Weissman--Director of the Respiratory Health Division for NIOSH (the National Institute for Occupational Safety and Health), and liaison to the Essential Workers team that is part of the CDC COVID-19 Vaccine Task Force, will join us for further discussion of issues specific to the workplace, including workplace vaccination policies, strengthening vaccine confidence, and available CDC COVID-19 vaccine resources and toolkits.
At the completion of this course participants should be able to:
- Describe at least 1 current issue and/or emerging trend in occupational and environmental medicine.
- Identify 2 new developments in understanding occupational and environmental medicine practice.
- Discuss 2 practical applications of new treatment options and prevention methods that can positively impact your practice.
- List 2 ways to improve collaborative practice across the public healthcare team.
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and the Northwest Center for Occupational Health and Sciences, University of Washington Department of Environmental and Occupational Health Sciences. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.2 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, our presenters and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Gottlieb and he wishes to disclose he receives author royalties, grant support and research funding from the following organizations:
U.S. National Institutes of Health, the University of Washington, the Bill & Melinda Gates Foundation, Gilead Sciences, Alere Technologies, Merck & Co., Janssen Pharmaceutica, Cerus Corporation, ViiV Healthcare, Bristol-Myers Squibb, Roche Molecular Systems, Abbott Molecular Diagnostics, and Theratechnologies/TaiMed Biologics, Inc.
Planning committee discussed conflict of interest with Dr. Gottlieb to ensure there is no bias.
Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
CANCELLATION POLICY: In the event you cannot attend the course, there are a few options -- you can either cancel your registration, transfer your registration to another course, or transfer your registration to another person. If you choose to cancel, we must receive your cancellation in writing with at least 1 week notice, and a refund will be issued minus a $49 cancellation fee. If you do not cancel and are a no-show for the course, your tuition fee is forfeited. If you choose to transfer your registration, please state the course you are transferring out of, and the course you are transferring into. Transferring to another course is permitted only twice per course registration. If you are unable to attend the course after the second transfer, the above cancellation policy applies.